arbitration
Adaptive Biotechnologies ImmunoSeq Dx Development Jolts Forward With Lyme Disease in Crosshairs
Premium
The immune sequencing firm has engaged the FDA in discussions over how to get regulatory approval for one test for several seemingly different diseases.
NeoGenomics Ordered to Pay Health Discovery $6.6M
The companies were involved in a dispute over NeoGenomics' handling of Health Discovery technology it licensed in 2012 to develop cancer tests.
10X Genomics Founders Prevail in Arbitration Dispute With Bio-Rad
Bio-Rad brought a claim before the American Arbitration Association in 2014, alleging that three 10X Genomics founders breached certain contractual obligations.
Roche Alleges CareDx Breached Contract, Seeking $3.5M
NEW YORK (GenomeWeb) – CareDx disclosed in a regulatory filing on Thursday that Roche is seeking an estimated $3.5 million from the firm for allegedly breaching a licensing deal the companies brokered in 2004.
Med BioGene Poised to take Precision Therapeutics to Arbitration over Milestone Payment
NEW YORK (GenomeWeb) – Med BioGene today announced that it is ready to initiate proceedings against its commercial partner Precision Therapeutics to enforce a C$1 million (US$920,000) milestone payment due to Med BioGene.
Jun 7, 2013
Oxford Nanopore, Illumina to Cut Ties
Jan 24, 2013
Feb 9, 2012
Mar 10, 2011
Oct 14, 2010